Sign Up to like & get
recommendations!
1
Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2021-001669
Abstract: Objectives To evaluate the long-term safety and efficacy of belimumab in patients with systemic lupus erythematosus (SLE) in China. Methods In this phase 3, open-label extension period, eligible completers of study BEL113750 (NCT01345253) received intravenous…
read more here.
Keywords:
belimumab patients;
year;
long term;
efficacy belimumab ... See more keywords